After-Hours Stock Movers:

Smartsheet (NYSE: SMAR) 20% LOWER; reported Q1 EPS of ($0.11), $0.08 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $85.5 million versus the consensus estimate of $81.29 million. Smartsheet sees Q2 2021 EPS of ($0.18)-($0.16), versus the consensus of ($0.14). Smartsheet sees Q2 2021 revenue of $86-87 million, versus the consensus of $88.23 million. Smartsheet sees FY2021 EPS of ($0.54)-($0.45), versus the consensus of ($0.57). Smartsheet sees FY2021 revenue of $360-370 million, versus the consensus of $370.17 million.

Air Transport Services Group (NASDAQ: ATSG) 13.1% HIGHER; Amazon (NASDAQ: AMZN) continues to adapt to meet the changing needs of customers by investing in ways to provide fast, free delivery. Today, the company announced the lease of 12 Boeing 767-300 converted cargo aircraft from Air Transport Services Group (NASDAQ: ATSG). These aircraft will join Amazons existing fleet of 70 aircraft to bring its total network to over 80 aircraft. One of the new aircraft joined Amazons air cargo operations in May 2020, with the remaining 11 to be delivered in 2021.

Cloudera, Inc. (NYSE: CLDR) 10.8% LOWER; reported Q1 EPS of $0.05, $0.05 better than the analyst estimate of $0.00. Revenue for the quarter came in at $210.5 million versus the consensus estimate of $204.62 million.Cloudera, Inc. sees Q2 2021 EPS of $0.06-$0.07, versus the consensus of $0.01. Cloudera, Inc. sees Q2 2021 revenue of $206-209 million, versus the consensus of $212.2 million. Cloudera, Inc. sees FY2021 EPS of $0.26-$0.30, versus the consensus of $0.23. Cloudera, Inc. sees FY2021 revenue of $825-845 million, versus the consensus of $858.37 million.

Comtech Telecom (NASDAQ: CMTL) 10.5% LOWER; reported Q3 EPS of ($0.16), $0.15 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $135.1 million versus the consensus estimate of $148.83 million.

Aileron Therapeutics (NASDAQ: ALRN) 8.4% LOWER; announced today that it has commenced an underwritten public offering of shares of its common stock. Aileron also intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering. All of the shares are being offered by Aileron.

Globant S.A. (NYSE: GLOB) 6.2% LOWER; today announced that it intends to offer and sell 2,000,000 of its common shares, subject to market and other conditions, in an underwritten public offering.

Twist Bioscience Corporation (NASDAQ: TWST) 6.1% LOWER; announced that it intends to offer and sell up to $100 million of shares of its common stock in an underwritten public offering.

Elastic N.V. (NYSE: ESTC) 4.6% LOWER; reported Q4 EPS of ($0.12), $0.19 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $123.6 million versus the consensus estimate of $116.95 million. Guides above views.

Tilly's, Inc. (NYSE: TLYS) 4.6% LOWER; reported Q1 EPS of ($0.59), $0.23 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $77.3 million versus the consensus estimate of $78.27 million.

Greif (NYSE: GEF) 4.4% HIGHER; reported Q2 EPS of $0.95, $0.20 better than the analyst estimate of $0.75. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.15 billion.

NetApp® (NASDAQ: NTAP) 3.5% LOWER; announced it has entered into a definitive agreement to acquire Spot, a leader in compute management and cost optimization on the public clouds, to establish leadership in Application Driven Infrastructure.

Guidewire Software (NYSE: GWRE) 3.3% HIGHER; reported Q3 EPS of $0.09, $0.14 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $168.2 million versus the consensus estimate of $152.63 million. Guides above views.

Fossil Group (NASDAQ: FOSL) 2.9% LOWER; reported Q1 EPS of ($1.69), versus ($0.25) reported last year. Revenue for the quarter came in at $390.7 million, versus $465.3 million reported last year.

Provention Bio Inc. (NASDAQ: PRVB) 2.2% HIGHER; Oppenheimer initiates coverage with a Outperform rating and a price target of $29.00.

Park Hotels & Resorts (NYSE: PK) 1.4% HIGHER; Director, Thomas Eckert, bought 30,000 shares on 6/1 at $10.50-$10.60.